Ventas Prices Cdn$775 Million of 2.45% Senior Notes Due 2027 and 3.30% Senior Notes Due 2031

Rhea-AI Summary

Ventas, Inc. has announced a private offering in Canada, pricing Cdn$475 million of 2.45% Senior Notes due January 4, 2027, and Cdn$300 million of 3.30% Senior Notes due December 1, 2031. The offering, managed by Ventas Canada Finance Limited, is expected to close on December 1, 2021. Proceeds will be used to redeem existing Senior Notes due 2022 and for general corporate purposes. The Notes will not be registered under the Securities Act and are offered only to accredited investors.

Positive

• Successful pricing of Cdn$475 million of 2.45% Senior Notes and Cdn$300 million of 3.30% Senior Notes.
• Funds will be used to redeem existing debt, potentially improving the company's financial position.

Negative

• Notes are not registered under the Securities Act, limiting marketability and investor access.

CHICAGO--(BUSINESS WIRE)-- Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) said today that it has priced a private offering in Canada of Cdn$475 million of 2.45% Senior Notes, Series G due 2027 (the “2027 Notes”) and Cdn$300 million of 3.30% Senior Notes, Series H due 2031 (the “2031 Notes”, and together with the 2027 Notes, the “Notes”). The sale of the Notes is expected to close on December 1, 2021.

The Notes are being issued by Ventas’ indirect, wholly-owned subsidiary, Ventas Canada Finance Limited (the “Issuer”), on a prospectus-exempt basis only to “accredited investors” who are not individuals unless such individuals are also “permitted clients,” in each case as defined under applicable Canadian securities laws. The Notes will be unconditionally guaranteed by the Company (the “Guarantees”).

The 2027 Notes will mature on January 4, 2027 and the 2031 Notes will mature on December 1, 2031. The Notes will constitute senior unsecured obligations of the Issuer and will rank equally with all other present and future unsecured and unsubordinated obligations of the Issuer. The Guarantees will constitute senior unsecured obligations of the Guarantor and will rank equally with all other present and future unsecured and unsubordinated obligations of the Company. Interest on the 2027 Notes will be payable semi-annually in arrears on January 4 and July 4 of each year, commencing on July 4, 2022. Interest on the 2031 Notes will be payable semi-annually in arrears on June 1 and December 1 of each year, commencing on June 1, 2022.

The Company expects to use a portion of the net proceeds from the sale of the Notes to fund the redemption of the Issuer’s 3.30% Senior Notes, Series C due 2022, which will be early-redeemed on December 8, 2021. The remaining net proceeds are expected to be used for general corporate purposes, which may include repayment of a portion of existing indebtedness of Ventas.

The Notes have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. The Notes have not been qualified by way of prospectus in any province or territory of Canada and may not be offered or sold to persons located or resident in Canada except pursuant to an exemption from the prospectus requirements of applicable Canadian securities laws.

Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries – healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, research & innovation properties; medical office & outpatient facilities, health systems and other healthcare real estate. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and forward looking information within the meaning of applicable Canadian securities laws (collectively, “forward-looking statements”). These forward-looking statements include, among others, statements of expectations, beliefs, future plans and strategies, anticipated results from operations and developments and other matters that are not historical facts. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “target,” “forecast,” “plan,” “potential,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof.

Forward-looking statements are based on management’s beliefs as well as on a number of assumptions concerning future events. You should not put undue reliance on these forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements. You are urged to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance in our filings with the Securities and Exchange Commission, including those made in the “Risk Factors” section and “Management’s Discussion & Analysis of Financial Condition and Results of Operations” section of our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q. We do not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made.

Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) the impact of the ongoing COVID-19 pandemic, including of the Delta or any other variant, on our revenue, level of profitability, liquidity and overall risk exposure and the implementation and impact of regulations related to the CARES Act and other stimulus legislation and any future COVID-19 relief measures; (b) our ability to achieve the anticipated benefits and synergies from the acquisition of, and the risk of greater than expected costs or other difficulties related to the integration of, New Senior Investment Group Inc.; (c) our exposure and the exposure of our tenants, borrowers and managers to complex healthcare and other regulation and the challenges and expense associated with complying with such regulation; (d) the potential for significant general and commercial claims, legal actions, regulatory proceedings or enforcement actions that could subject us or our tenants, borrowers or managers to increased operating costs and uninsured liabilities; (e) the impact of market and general economic conditions, including economic and financial market events, or events that affect consumer confidence, our occupancy rates and resident fee revenues, and the actual and perceived state of the real estate markets, labor markets and public capital markets; (f) our ability, and the ability of our tenants, borrowers and managers, to navigate the trends impacting our or their businesses and the industries in which we or they operate; (g) the risk of bankruptcy, insolvency or financial deterioration of our tenants, borrowers, managers and other obligors and our ability to foreclose successfully on the collateral securing our loans and other investments in the event of a borrower default; (h) our ability to identify and consummate future investments in or dispositions of healthcare assets and effectively manage our portfolio opportunities and our investments in co-investment vehicles; (i) our ability to attract and retain talented employees; (j) the limitations and significant requirements imposed upon our business as a result of our status as a REIT and the adverse consequences (including the possible loss of our status as a REIT) that would result if we are not able to comply; (k) the risk of changes in healthcare law or regulation or in tax laws, guidance and interpretations, particularly as applied to REITs, that could adversely affect us or our tenants, borrowers or managers; (l) increases in our borrowing costs as a result of becoming more leveraged or as a result of changes in interest rates and phasing out of LIBOR rates; (m) our reliance on third parties to operate a majority of our assets and our limited control and influence over such operations and results; (n) our dependency on a limited number of tenants and managers for a significant portion of our revenues and operating income; (o) the adequacy of insurance coverage provided by our policies and policies maintained by our tenants, managers or other counterparties; (p) the occurrence of cyber incidents that could disrupt our operations, result in the loss of confidential information or damage our business relationships and reputation; (q) the impact of merger, acquisition and investment activity in the healthcare industry or otherwise affecting our tenants, borrowers or managers; and (r) the risk of catastrophic or extreme weather and other natural events and the physical effects of climate change.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005984/en/

Sarah Whitford

(877) 4-VENTAS

Source: Ventas, Inc.

FAQ

What is the amount Ventas raised in the recent private offering?

Ventas raised a total of Cdn$775 million from the private offering.

When will the Notes mature for Ventas?

The 2027 Notes mature on January 4, 2027, while the 2031 Notes mature on December 1, 2031.

What is the purpose of the proceeds from the Ventas offering?

Proceeds will be used for redeeming existing Senior Notes due 2022 and for general corporate purposes.

Who can purchase the new Senior Notes from Ventas?

The Notes are offered only to accredited investors who are not individuals unless they are also permitted clients.

What are the interest terms for the Ventas Senior Notes?

Interest on the 2027 Notes will be paid semi-annually starting July 4, 2022, and the 2031 Notes will have interest payments starting June 1, 2022.